NCI Standard Funding Opportunity Announcements
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
August 11 |
Jr. Faculty |
Moffitt Funding |
Team Science |
Moffitt Medical Group (MMG)
Junior Faculty Team Research Award Cycle I
Promotes exploration of innovative ideas and establishment of new
collaborations. MMG Junior Faculty Team Research Award may be
awarded to investigators working with animal models, or to
investigators using human tissue, fluid or blood samples for
pre-clinical studies.
Due Date |
August 11 (Single pdf file to
Kim Murphy by 4:00pm) |
Amount & Project Period: |
$20,000 to $50,000 - 1 year |
Eligibility: |
MD or PhD, and member of Moffitt Medical Group
(MMG). Must have a track record of productivity. Those new to cancer
research will receive priority. |
Contact: |
Kim
Murphy (x1432) |
RFA Link: |
MMG Jr. Faculty Team Research Guidelines Ι
Application |
|
|
August 12 |
All Faculty |
Federal |
Conference Support |
NIH Support for Conferences and Scientific Meetings (Parent
FOA)
Supports high quality conferences relevant to the public health and to
the scientific mission of the participating Institutes and
Centers.
Due Dates: |
Standard Dates August 08 (OSR) Ι August 12 (Sponsor) |
Amount & Project Period: |
Most ICs accepts applications for up to 5 years
of support for a series of annual or biannual conferences proposed by a
permanently sponsoring organization. Support for conferences held on a
less frequent schedule must be applied for individually. The
appropriate
NIH Conference Grant Contact should be consulted for guidance |
Eligibility: |
All faculty |
Contact: |
Linda Nolan (x6071) |
RFA Link: |
PA-13-347 |
|
|
August 13 |
Postdocs/Jr Faculty |
Non-federal |
Lung Cancer |
Uniting Against Lung Cancer (UALC)
Legacy Program
Seed money for promising and potentially transformative new projects.
Interdisciplinary collaborations strongly encouraged. Does not require
large amounts of preliminary data, but must have a clear hypothesis
and research plan.
Due Dates: |
August 11 (OSR)
Ι August 13 (Sponsor)
|
Amount & Project Period: |
$50,000/year (Incl. 10% F&A)
- 2 years
|
Eligibility: |
Hold a faculty appointment or be
mentored by a faculty member
|
Contact: |
Linda Nolan
(x6071)
|
Links: |
Legacy Program (Guidelines)
Uniting Against Lung Cancer (Funding Opps. Page) |
|
|
August 15 |
Postdoc/Fellows |
Non-federal |
Career Development |
Damon Runyon Fellowship Award
Supports all theoretical and experimental research relevant to the
study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Due Dates: |
August 13 (OSR)
Ι
August 15 (Sponsor)
|
Amount & Project Period: |
3-year period
Level 1: Stipend: $50,000/yr. Allowance: $2,000/yr
Level 2: Stipend: $60,000/yr. Allowance: $2,000/yr.
|
Eligibility: |
Level 1 Funding: Basic and physician-scientist
-
degree received
Less than 1 year prior to the Fellowship Award Committee (FAC) meeting when application is considered, and not have been in Sponsor's lab
more than 1 year prior to meeting.
Level 2 Funding: Physician-scientist applicant - (MD, MD/PhD, DDS, DVM or equiv.) must have completed residency
& clinical training and be board-eligible in U.S. at award.
Postdoctoral fellows, clinical fellows and clinical instructors are eligible. Foreign candidates may apply to do research only in U.S.
|
Contact: |
Linda Nolan (X6071)
|
Link: |
Fellowship Application Guidelines
|
|
|
August 15 |
All Ranks |
Federal |
Smoking Cessation |
Exploratory Studies of Smoking Cessation Interventions for
People with Schizophrenia
Applications to generate and conduct preliminary tests of targeted smoking cessation treatments for individuals with schizophrenia. Applications that focus on early-stage,
treatment generation and pilot clinical trials that are consistent with an experimental therapeutic approach are encouraged.
Due Dates: |
August 13 (OSR) Ι August
15 (Sponsor) |
Amount & Project Period: |
R21: $275,000/year (Direct Costs) - 2 years
R33: $450,000 (Direct Cost Total)
- 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (X6071) |
FOA Link: |
PAR-14-230 |
|
|
August 15 |
All Ranks |
Federal |
Smoking Cessation |
Exploratory Studies of Smoking Cessation Interventions for
People with Schizophrenia
Type I will conduct exploratory testing of novel, targeted
treatments for smoking cessation for individuals with
schizophrenia. Type II will conduct exploratory testing of
targeted implementation strategies of existing efficacious
treatments at the service-delivery system level.
Due Dates: |
August 13 (OSR) Ι August
15 (Sponsor) |
Amount & Project Period: |
$450,000 (Direct Cost Total)
- 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-14-231 |
|
|
August 15 |
Jr Faculty |
Federal |
Breast |
Congressionally Directed Medical Research Programs
Breast Cancer Research Program (BCRP)
Era of Hope Scholar Award
Central feature of the award is innovative contribution of PI/PD toward ending breast cancer. PI should
articulate a vision challenging current dogma & demonstrating
ability to look beyond tradition and convention.
Due Dates: |
August
1 (Pre-application)
Aug 13 (OSR) Ι Aug 15 (Sponsor) |
Amount & Project Period: |
$2,500,000 (Direct Costs) - 5 years |
Eligibility: |
Jr. Faculty - Independent investigator w/in 6
years of last training position |
Contact: |
Linda Nolan (x6071) |
PA Link: |
W81XWH-14-BCRP-EOHS (Program Announcement) |
|
NEW |
August 15 |
Faculty/Research Scientists |
Non-federal |
Pediatric Cancers |
Research Grants - Summer Cycle 2014
Pediatric cancer-related research projects: 1. Critical translational
research leading to a future clinical trial; use of Sunshine
Project lab possible 2. Research conducted within the pediatric
Total Cancer Care (pedsTCC) protocol.
Due Dates: |
August 15 (by 4:00 to
Maureen Ahearn) |
Amount & Project Period: |
$100,000 - 1 year |
Eligibility: |
Faculty or staff at Sunshine Project member
institutions; Research Scientists are eligible to apply; a letter of
support from Program Leader/Chair is required |
Contact: |
Maureen Ahearn (x8824) or
Kathleen Manning
(x7412) |
|
|
August 15 |
All Ranks |
Non-Federal |
Pancreatic Cancer |
Hershberg Foundation for Pancreatic Cancer Research Seed Grants
To provide start-up funding to test innovative ideas for improving diagnosis and to develop new treatment modalities
in pancreatic cancer; obtain preliminary data required for additional funding
impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy
and to establish collaborations within the field.
Due Dates: |
August 13 (OSR)
Ι
August 15 (Sponsor)
|
Amount & Project Period: |
$50,000 - 1 year (Renewable)
|
Eligibility: |
All Ranks
|
Contact: |
Linda
Nolan, x6071
|
RFA Link: |
Seed Grants
|
|
NEW |
August 15 |
Postdocs/Faculty |
Non-federal |
Women's Health |
Foundation for Women's Wellness
Fellowship Awards
Focus is on basic, clinical or epidemiological lines of inquiry
|
NEW |
Foundation for Women's Wellness
2014 Women's Health Research Awards
Early funding for small, short-term research in women's health
topics w/emphasis on top female cancers, hormones' role in disease
and/or stage-of-life health concerns, and topics
disproportionately affecting women
|
NEW
|
August 17 (LOI) |
All Faculty |
Federal |
Screen-detected Lesions |
Molecular and Cellular Characterization of Screen-Detected
Lesions - Coordinating Center and Data Management Group
Applications for a Coordination and Data Management Group (CDMG)
to conduct biological analysis of screen-detected,
interval-detected, and symptom-detected cancers.
Responsibilities will be: 1) coordination of consortium-wide
meetings and conferences, and collaborative activities; 2)
statistical support and computational analysis; and 3) data
management and protocol development for the biorepository.
Due Dates: |
Aug 17 (LOI)
Ι September 15 (OSR) Ι September 17 (Sponsor) |
Amount & Project Period: |
Not to exceed $300,000 (Direct costs) - 3 years |
Eligibility: |
All Faculty |
Contact: |
Linda Nolan (x6071) |
RFA Link: |
RFA-CA-14-011 |
|
NEW |
August 18 (LOI) |
Postdocs/Jr. Faculty |
Non-federal |
Smoking-related |
Flight Attendant Medical Research Institute
Clinical Innovator Awards
Subject matter of applications is limited to the effect of
second hand tobacco smoke exposure on respiratory diseases.
Proposals must deal with the following topic areas:
Chronic sinusitis, including cilia abnormalities or
alterations
Chronic obstructive pulmonary disease (COPD), including
chronic bronchitis and emphysema
FAMRI is interested in clinical and translational research, from
basic molecular mechanisms of disease to occupational health.
Due Date |
Aug 18 (Letter of Intent) Ι Oct 09 (OSR) Ι
Oct 13 (Sponsor) |
Amount & Project Period: |
$100,000 (Direct Costs) - 3 years |
Eligibility: |
Assistant Member or above (must have 50%
overall research effort) No citizenship requirement |
Contact: |
Linda Nolan (X6071) |
Links: |
Current and Upcoming Awards Ι
Letter of Intent Guidelines |
|
NEW |
Young Clinical Scientist Awards
Subject matter is limited to the effect of second hand tobacco
smoke exposure on respiratory diseases in the following topic
areas: Chronic sinusitis, including cilia abnormalities or
alterations Chronic obstructive pulmonary disease (COPD),
including chronic bronchitis and emphysema FAMRI is interested
in clinical and translational research, from basic molecular
mechanisms of disease to occupational health.
Due Date |
August 18 (Letter of Intent)
Invited Submissions: October 09 (OSR) Ι October 13
(Sponsor) |
Amount & Project Period: |
Research Fellow: $75,000 (Direct Costs)
- 2 years
Jr. Faculty:
$100,000/year (Direct Costs)
- 5 years |
Eligibility: |
Research Fellows
(will begin faculty appt. before July 1, 2015) Must commit 70% effort to
proposed research
Junior Faculty (Asst. Member
for < 3 years) Must have 75% overall research effort & commit 35%
of that to this project No citizenship requirement |
Contact: |
Linda
Nolan (X6071) |
RFA Link: |
Current and Upcoming Awards Ι
Letter of Intent Guidelines |
|
NEW |
August 20 (Pre-app) |
Established Investigators |
Federal |
Research Support |
NCI Outstanding Investigator Award (OIA) (R35)
Support for investigators with outstanding records of
productivity in cancer research. Will allow funded
investigators to embark on long-term projects of unusual
potential in cancer research; opportunity to take greater
risks and be more adventurous in lines of inquiry; and
sufficient time to develop new techniques.
Due Date |
Aug. 20 (Pre-app) to
Maureen Ahearn (x8824) |
Amount & Project Period: |
$600,000/year (Direct Costs) - 7 years |
Eligibility: |
Outstanding record of productivity in cancer
research Recipient of NCI grant(s) for at least the past 5 years
Able to commit at least 50% effort to the OIA
Able to renegotiate time and effort on other NIH Grants to accommodate
the OIA |
Contact: |
Maureen Ahearn (x8824)
Pre-applications must include current NIH biosketch with a
detailed personal statement summarizing cancer highlights. PDF format
required. |
RFA Link: |
PAR-14-267 |
|
NEW |
August 27 |
Postdocs/Faculty |
Non-federal |
Prevention |
Prevent Cancer Foundation
Fall 2014 Grant and Fellowship Program
Innovative research for improvement of early detection and intervention,
on dietary links to cancer, behavioral/educational aspects of
cancer prevention, epidemiological and genetic studies that may
have direct impact on cancer prevention, and primary prevention
programs that focus on children and adolescents.
Due Date |
August 25 (OSR) Ι August 27 (Sponsor) |
Amount & Project Period: |
$80,000 - 2 years |
Eligibility: |
Grant: All Faculty
- See guidelines
Fellowship: Postdoctoral level
Application fee is $75.00 |
Contact: |
Linda Nolan (x6071) |
RFA Link: |
Grant Guidelines Ι
Fellowship Guidelines |
|
|
August 27 (Pre-app.) |
Postdocs |
Federal |
Career Development |
Prostate Cancer Research Program
Postdoctoral Training Award
Supports prostate cancer research training opportunities for recent doctoral graduates.
Due Dates: |
August 27 (Pre-app)
Ι
Sept 08 (OSR) Ι Sept 10 (Sponsor)
|
Contact: |
Linda Nolan (x6071) |
Amount & Project Period: |
$57,500/year (Direct Costs) - 2 years
|
Eligibility: |
Postdocs
|
PA Link: |
W81XWH-14-PCRP-PTA
|
|
|
Physician Research Training Award
Supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research.
Emphasizes equally the quality of both the research and the training proposed.
Amount & Project Period: |
$130,000/year (Direct Costs) - 4 years
|
Eligibility: |
Must be a physician with clinical duties in the last year as resident/fellow or within 3 years of Jr
Faculty appointment.
|
PA Link: |
W81XWH-14-PCRP-PRTA
|
|
|
August 29 |
Established Faculty |
Non-federal |
Gastric Cancer |
R. Robert & Sally Funderburg Research Award in Gastric Cancer
Novel approaches in gastric cancer research, including: gastric mucosal cell biology;
regeneration and regulation of cell growth; inflammation as precancerous lesions; genetics of gastric carcinoma;
oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial
malignancies; or clinical research in diagnosis or treatment of gastric carcinoma.
Due Dates: |
August 27 (OSR) Ι
August 29 (Sponsor)
|
Amount & Project Period: |
$50,000/year - 2 years |
Eligibility: |
Established Investigator in Gastric Biology
AGA membership required at time of submission |
Contact: |
Linda Nolan, x6071
|
RFA Link: |
Research Award in Gastric Cancer |
|
|
September 01 |
Jr. faculty |
Non-federal |
See Programs Below |
PhRMA Foundation
Due Dates: |
August 28 (OSR) Ι September 01 (Sponsor) |
Contact: |
Linda
Nolan, x6071 |
Primary Link: |
2015 Awards
|
Pre-doctoral fellowships: |
$20,000/year - 2 years |
Postdoctoral Fellowships: |
$40,000 stipend only/year - 2 years |
Research Starter Grants: |
$100,000 - 1 year |
Center for Adherence Improvement
Support for career development activities of individuals prepared to engage in research that is aimed at improving medication adherence. Relevant research goals include development or evaluation of policies, interventions, or tools potentially successful in improving medication adherence.
Pre-doctoral Fellowship |
Full-time, advanced, in-residence PhD candidates in the field of pharmaceutics. Must hold a BS, MS, or PharmD in pharmacy or a related area such as chemistry or biology
|
Post Doctoral Fellowships |
Must hold a PhD degree in pharmaceutics or a related discipline from
an accredited U.S. university or expect to receive such a degree before
activation of fellowship
|
Research Starter Grants |
Must be in a tenure track position 3 or less years w/a rank of instructor
or asst. professor and doctoral level investigators w/equivalent positions Proposed research may not be subsidized to any significant degree by a competitive extramural grant. US citizen/permanent resident only.
|
|
|
Informatics ProgramPromotes development and use of informatics in an integrative approach towards understanding human biological and disease processes. Preference is for research that combines novel computational methods together with experimental validation.
Proposals must contain innovative informatics components, and not solely apply bioinformatic methodologies to experimental data analysis.
Predoctoral Fellowship -
Two applications per institution |
Full-time, advanced, in-residence PhD candidates in the fields of informatics
|
Postdoctoral Fellowship |
Must either hold a PhD degree in an area logically or functionally related to the proposed postdoctoral activities, or expect to receive the PhD before activation of award. US citizens and Permanent residents.
|
Research Starter Grants |
Jr. Faculty - Tenure track |
|
|
Pharmacology/Toxicology ProgramResearch that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, either in experimental animal or clinical studies or both. Priority is given for research attempting to integrate information on the mechanism of action of a drug or chemical at the molecular or cellular level with the drug effect observed in a human or laboratory animal.
Due Date: |
August 29 (OSR) Ι
September 01 (Sponsor) |
Pre Doctoral Fellowships - 1
application per institution |
Full-time, advanced, in-residence PhD candidates in the fields of pharmacology or toxicology |
Post Doctoral Fellowships |
Must either hold a PhD degree in an area logically or functionally related to the proposed activities or expect to receive the PhD before activation of award. |
Research Starter Grants |
Academic rank of instructor or assistant professor and doctoral level investigators w/equivalent positions.
Proposed research may not be subsidized by a competitive extramural grant. |
|
|
Pharmaceutics
Research that integrates information on molecular or cellular
mechanisms of action with information on the effects of an agent
observed in an intact organism, either in experimental animal or
clinical studies or both. Priority given for research attempting
to integrate information on the mechanism of action of a drug or
chemical at the molecular or cellular level with the drug effect
observed in a human or laboratory animal.
Pre Doctoral Fellowships |
Full-time, advanced, in-residence PhD candidates in the field of
pharmaceutics. Must hold a BS, MS, or PharmD in pharmacy or a
related area such as chemistry or biology
|
Post Doctoral Fellowships |
Must hold a PhD degree in pharmaceutics or a related discipline from
an accredited US university or expect to receive such a degree before
activation of fellowship
|
Research Starter Grants |
Must be in a tenure track position <3
years w/rank of instructor or asst. professor & doctoral level
investigators w/equivalent positions Proposed research may not be
subsidized to any significant degree by a competitive extramural grant. |
|
|
September 3 |
All Faculty |
Non-federal |
Team Science |
AACR Team Science Award
The research to be recognized should reflect work towards a
specific scientific goal that otherwise would not be realized by
any single component of the team.
Due Date |
September 01 (OSR) Ι September
03 (Sponsor) |
Amount & Project Period: |
$50,000 |
Eligibility: |
Team is comprised of independent faculty-level researchers who may be working w/in same institution or at several institutions |
Contact: |
Linda
Nolan (x6071) |
Link: |
2015 AACR Team
Science Award |
|
NEW
|
September 3 |
Postdocs/Jr Faculty |
Non-federal |
Lymphoma |
Lymphoma Research Foundation
Clinical Investigator Career Development Award RFP
Supports physician investigators who will contribute to the
development of new lymphoma therapies and diagnostic tools.
Amount & Project Period: |
$225,000 - 3 years |
Eligibility: |
MD with less than 5 years' experience after postdoc
training |
Postdoctoral Fellowship
Grant RFP
Laboratory or clinic based research w/results & conclusions
clearly relevant to the treatment, diagnosis or prevention of
Hodgkin and/or non-Hodgkin lymphoma. Areas of research may
include, but are not limited to, etiology, immunology, genetics,
therapies and transplantation.
Amount & Project Period: |
$105,000 - 2 years |
Eligibility: |
Completed 2 years of postdoc training or have <
2 years as instructor/assistant member at award and spend 80% time on
research. |
Lymphoma Clinical
Research Mentoring Program RFP
A Training Program with a focus on Clinical Research in the
field of non-Hodgkin and Hodgkin lymphoma. Projects must be
focused on a proposed hypothesis-driven clinical research
project in lymphoma.
Amount & Project Period: |
$10,000 - 2 years |
Eligibility: |
Jr. Faculty in first 3 years or trainees in at
least 2nd year of one of the ACGME accredited fellowship programs:
Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology,
or Hematopathology |
Adolescent/Young Adult (AYA) Cooperative Group Correlative
Studies
For correlative clinical/translational studies in
adolescent/young adult (AYA) lymphomas. Applications must be an
adjunct to a major National Cancer Institute (NCI) cooperative
group research project in lymphoma. Projects should also relate
to work in the clinical setting and/or involve primary lymphoma
patient samples
|
NEW |
September 05 (LOI) |
All Faculty |
Non-federal |
Patient-centered Outcomes |
Patient-Centered Outcomes Research Institute
Fall 2014 PCORI Funding Cycle
1. Assessment of Prevention, Diagnosis, and Treatment Options
2. Improving Healthcare Systems
3. Communication and
Dissemination Research
4. Addressing Disparities
5. Improving Methods for Conducting Patient-Centered Outcomes
Research
Due Date |
Sept 05 (Letter of Intent) Ι Oct 31 (OSR)
Ι Nov 4 (Sponsor) |
Amount & Project Period: |
To be Determined |
Eligibility: |
All faculty |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
Upcoming Opportunities |
|
NEW
|
September 07 |
All Ranks |
Federal |
HIV |
Multidisciplinary Studies of HIV and Viral Hepatitis
Co-Infection
To increase understanding of a) the pathogenic interactions
between HIV and hepatitis viruses, b) co-morbidities associated
with HIV/hepatitis virus co-infection, and c) the effectiveness
of interferon-free direct-acting antiviral drug regimens to
treat HIV/HCV co-infection.
Due Dates: |
Standard AIDS dates Ι Sept 04 (OSR) Ι Sept 07 (Sponsor) |
Amount & Project Period: |
R01: Budget not limited - 5 years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Links: |
PAR-14-255 (R01) |
PAR-14-254 (R21) |
|
NEW |
September 08 (LOI) |
Postdocs/ Jr Faculty |
Non-federal |
Leukemia/Lymphoma |
Leukemia & Lymphoma Society
Career Development Program (CDP)
Scholar and Scholar in Clinical Science Awards
These awards are designed for investigators who show capacity
for independent, sustained original research in hematologic
malignancies
Amount & Project Period: |
$110,000/year - 5 years |
Eligibility: |
Scholar:
Faculty-level, tenure-track (or equivalent) position, held for
< 8 years at time of
review (Jan 1, 2015). Must bePD/PI on a peer-reviewed research grant
from a national agency
Scholar in Clinical Research:
independent faculty-level position conducting original,
independent applied research, often involving early-stage clinical
trials to advance prevention, diagnosis or treatment of hematologic
malignancies |
Contact: |
Linda
Nolan (X6071) |
RFA Links: |
Scholar Ι
Scholar in Clinical Research |
|
NEW |
Leukemia & Lymphoma Society
Career Development Program (CDP)
Special Fellow and Special Fellow in Clinical Research Awards
Applicants must show a capacity for independent, original
investigation in a field directly relevant to hematologic
malignancies. Special Fellows will be competitive for an
independent position by end of grant period.
Amount & Project Period: |
$65,000/year - 2 to 3 years |
Eligibility: |
At least 2 yrs. postdoc experience, but less
than 4-1/2 years of experience at time of review (January 1, 2015)
Awardee must spend at least 1 year in sponsor lab |
Contact: |
Linda
Nolan (x6071) |
RFA Links: |
Special Fellow Ι
Special Fellow in Clinical Research |
|
NEW |
Leukemia & Lymphoma Society
Career Development Program (CDP)
Fellow Award
Encourages an academic career involving clinical or fundamental research
in, or related to, leukemia, lymphoma or myeloma under a
research sponsor's direction
|
|
September 10 (LOI) |
All Faculty |
Federal |
Innovative Research |
NIH Transformative Research Awards
Supports individual scientists or groups of scientists proposing
groundbreaking, exceptionally innovative, original and/or
unconventional research with the potential to create new
scientific paradigms, establish entirely new and improved
clinical approaches, or develop transformative technologies.
Little or no preliminary data are expected. Projects must
clearly demonstrate the potential to produce a major impact in a
broad area
Due Date |
Sept 10 (LOI) Ι Oct 08 (OSR) Ι Oct 10 (Sponsor) |
Amount & Project Period: |
Budget not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-RM-14-003 |
|
|
Sept 11 |
All Faculty |
Federal |
Radiation |
Decreasing Patient Radiation Dose from CT Imaging:
Achieving Sub-mSv Studies
To encourage research leading to reduction of patient radiation exposure
from a CT scan. The goal is that research outcomes will result
in routine CT scan patient radiation exposures of <1 mSv
Due Date |
September 09 (OSR) Ι September 11 (Sponsor) |
Amount & Project Period: |
Budget not limited - 4 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
PAR-12-206 |
|
|
September 15 |
All Ranks |
Non-federal |
Desmoid Tumors |
Desmoid Tumor Research Foundation
Due Dates: |
September 11 (OSR) Ι September 15 (Sponsor) |
Contact: |
Shaina Sine (x3658) |
2014 New Investigator Grants
Funds early stage research to explore new approaches to
advancing current scientific knowledge about desmoid tumors.
Seeks young investigators new to desmoid tumor research and in
need of seed funding to gather preliminary data
Amount & Project Period: |
$30,000 (Total) - 1 year |
Eligibility: |
MD, PhD, or equivalent degree at or below level of Associate Professor |
RFA Link: |
2104
New Investigator RFA |
2014 Research Grant
Funds research to advance current scientific knowledge about
desmoid tumors using cutting-edge science and creative clinical
applications, in addition to novel approaches addressing
potential leads based on prior research
Amount & Project Period: |
$65,000/year - 1 year |
Eligibility: |
MD, PhD, or equivalent degree |
RFA Link: |
2104 Research Grant RFA |
|
|
September 15 |
Principal Investigators |
Non-federal |
All Areas |
The American Society for Pharmacology and Experimental
Therapeutics - The David Lehr Award
Supports proposals for investigators seeking "bridge" funds to enhance a
grant application for competitive renewal, additional funds for
a research project supported by a "no cost extension" to enhance a resubmission, or funds to acquire preliminary data
in support of a new grant submission.
Due Dates: |
September 12 (OSR) Ι September 15 (Sponsor) |
Amount & Project Period: |
$50,000/year - 2 years |
Eligibility: |
Investigators in need of bridge funding (see
above) Membership in ASPET required |
Contact: |
Linda
Nolan (X6071) |
RFA Link: |
ASPET
The David Lehr Award
(Guidelines) |
|
|
September 15 |
Postdocs |
Non-federal |
Career Development |
Sloan Research Fellowships
To stimulate fundamental research by early-career scientists and scholars of outstanding promise
A program designed to stimulate fundamental research by early career scientists and scholars of outstanding promise.
Due Dates: |
September 11 (OSR) Ι September 15 (Sponsor)
|
Amount & Project Period: |
$50,000 - 2 years
|
Eligibility: |
Candidates must hold a tenure track position at a degree-granting institution
that includes a yearly teaching requirement. They must hold a PhD,
awarded on or after September 2008, in chemistry, computational or evolutionary molecular biology, computer science, economics, mathematics, neuroscience, ocean sciences, physics, or a related field. |
Contact: |
Linda Nolan, (x6071)
|
|
NEW |
September 18 |
Postdocs |
Non-federal |
Career Development |
The Hope Funds for Cancer Research
Postdoctoral Fellowship
Innovative research projects that
challenge traditional paradigms of understanding of causes,
mechanisms, progression, disease markers or risk factors of the
most difficult-to-treat cancers, including pancreatic, lung,
liver, sarcomas, esophageal, brain, gastric, bone and ovarian
cancers; and rare leukemias, lymphomas and MDS.
Due Date |
September 11 (OSR) Ι September 15 (Sponsor) |
Amount & Project Period: |
Stipends:
$48,000 (year 01)
$50,000 (year 02)
$52,000 (year 03)
$1,500 (Travel allowance each year)
|
Eligibility: |
MD, PhD, MD/PhD, DDS, DVM. For foreign-trained
physicians, equivalency will be determined on a case-by-case basis. |
Contact: |
Linda Nolan (X6071) |
Links: |
The Postdoctoral Fellowship
Grant Criteria Guidelines |
|
NEW |
September 22 |
All Faculty |
Non-federal |
Prostate |
2014 PCF Global Treatment Sciences (GTSN) Challenge Award
for Lethal Prostate Cancer
Large-scale team science research projects on lethal prostate
cancer to support the correlative research around either
clinical trials of novel agents or strategies of standard of
care. Emphasis on developing or validating biomarkers that
guide therapy in patients or further understanding of mechanism
by which therapies work
Due Date |
September 18 (OSR) Ι September 22 (Sponsor) |
Amount & Project Period: |
$1,000,000 (Total) - 3 years |
Eligibility: |
Established investigators from one or several
institutions Must include at least 1 young investigator w/in 6 years of
completing professional degree or clinical training |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA Ι
Prostate Cancer Research |
|
|
September 25 |
All faculty |
Federal |
Program Projects |
National Cancer Institute Program Project Applications
Projects may address any of the broad areas of cancer research, including
(but not limited to cancer biology, cancer treatment, cancer
diagnosis, cancer prevention, and cancer control. Basic,
translational, clinical, and/or population-based studies in all
of these research areas are appropriate. Each Program Project
application must consist of at least three projects. The
projects must share a common central theme, focus, and/or
overall objective.
Due Date |
Sept 23 (OSR) Ι Sept 25 (Sponsor) |
Amount & Project Period: |
Budgets not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
PAR-13-321 |
|
NEW |
September 25 |
Young Clinical Investigators |
Non-federal |
Career Development |
Conquer Cancer Foundation
Career Development Award
Provides funding to clinical investigators holding initial
faculty appointments to establish independent clinical cancer
research programs. Application submissions are welcome in all
oncology subspecialties.
Due Date |
September 23 (OSR) Ι September 25 (Sponsor) |
Amount & Project Period: |
$200,000 - 3 years |
Eligibility: |
- Must be w/in 1st to 3rd year of a full-time, primary faculty
appointment
- Be an ASCO member or submit membership application w/proposal
- Ability to commit more than 50% of full-time effort in research
(applies to total research, not just proposed project) during award
period.
|
Contact: |
Linda
Nolan, x6071 |
Links: |
Career Development Award Ι
Request for Proposals |
|
NEW |
Young Investigator Award
To encourage and promote quality research in clinical oncology The purpose
is to fund physicians during transition from fellowship program
to faculty appointment.
Due Dates: |
September 23 (OSR) Ι September 25 (Sponsor) |
Amount & Project Period: |
$50,000 - 1 year |
Eligibility: |
- Be in the last two years of final subspecialty training at the
time of proposal submission
- Be an ASCO member or submit membership application w/proposal
- Be able to commit at least 60% of full- time effort in research
(applies to total research, not just the proposed project) during
the award period.
A US-trained MD, PhD is eligible if both degrees are completed prior
to start of grant period. For foreign-trained physicians, eligibility
for those currently enrolled in PhD programs will be determined on a
case by case basis, please contact
grants@conquercancerfoundation.org for eligibility
verification
|
Links: |
Young Investigator Award) Ι
Request for Proposals |
|
|
September 30 |
All Faculty |
Non-federal |
Scientific Achievement |
National Foundation for Cancer Research
(NFCR)
2015 Szent-Gyorgyi Prize
Annual prize, in honor of Albert Szent-Gyorgyi, Nobel Laureate and co-founder of NFCR, awarded to an outstanding researcher whose scientific achievements have
expanded understanding of cancer and whose discoveries have made possible new approaches to preventing, diagnosing, and/or treating cancer.
|
|
October 01 |
All Ranks |
Non-federal |
Early Detection |
American Society for Blood and Marrow Transplantation
New
Investigator Awards
To encourage clinical or laboratory research by young investigators in the
field of blood and marrow transplantation
Due Dates: |
September 29 (OSR) Ι October 01 (Sponsor) |
Amount & Project Period: |
$30,000/year - 2 years |
Eligibility: |
Must be post-doctoral fellows or
at the junior faculty level (instructor or assistant professor), < 3
years past a post-doctoral program or a clinical research fellowship |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
Guidelines |
|
|
October 01 |
Postdocs |
Non-federal |
Immunology Career Trng. |
Irvington Post Doctoral Fellowships
Provides critical financial support
and continued career training in cancer immunology.
Due Dates: |
September 29 (OSR) Ι October 01 (Sponsor)
|
Amount & Project Period: |
3 Years:
$50,000 - Year 1
$53,000 - Year 2
$57,000 - Year 3
$1,500/year for research support
|
Eligibility: |
Must have doctoral degree by date of award activation
and have less than 5 years relevant postdoctoral experience with the exception of MD applicants, who should not include years of residency in this calculation.
|
Contact: |
Linda
Nolan (X6071)
|
RFA Link: |
Irvington Post
Doctoral Fellowships
|
|
|
October 01 |
All Ranks |
Non-federal |
Career Trng. |
Elsa U. Pardee Foundation
Research Grants
Research directed toward identifying new treatments or cures for cancer,
particularly encouraging applications for a one year period which will
allow establishment of capabilities of new cancer researchers, or new
cancer approaches by established cancer researchers.
|
NEW
|
October 04 (LOI) |
All Faculty |
Federal |
Population Science |
Bridging the Gap Between Cancer Mechanism and Population Science
Incorporating insights and data from one end of the cancer
research spectrum into the framework of the other, projects
should cross-validate data gathered at different scales, and
explore links between basic biology, population science, and
potential health applications in treatment, prevention,
diagnosis, and/or screening.
Due Dates: |
October 4 (LOI) Ι November 1
(OSR) Ι November 4 (Sponsor) |
Amount & Project Period: |
Up to $700,000/year (Direct Cost) - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-13-081 |
|
NEW
|
October 03 (LOI) |
All Faculty |
Federal |
Nanotechnology |
Centers of Cancer Nanotechnology Excellence (CCNE)
CCNEs are designed to link physical scientists, engineers, & technologists
working at the nanoscale w/cancer biologists & oncologists
specializing in diagnosis, prevention, and/or treatment of
cancer NCI will hold a pre-application informational webinar
for this FOA. Date, time, and other details will be posted at
http://nano.cancer.gov/phase3info.
Due Date |
October 03 (Letter of Intent) Ι Oct 30
(OSR) Ι Nov 03 (Sponsor) |
Amount & Project Period: |
$2.6 million/year (TOTAL) - up to 5 years |
Eligibility: |
Multiple PDs/PIs are required. Identify at
least one senior investigator (PD/PI) to lead clinical translational
oncology and another senior investigator (PD/PI) to lead the applied
nanotechnology. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-14-013 |
|
NEW
|
October 05 |
All Ranks |
Federal |
Chemical Probes |
High Throughput Screening (HTS) to Discover Chemical Probes
To stimulate research in 1) discovery and development of novel,
small molecules for their potential use in studying disease
treatments relevant to the missions of the participating NIH
Institutes, and 2) discovery and/or validation of novel,
biological targets that will inform studies of disease
mechanisms. Emphasis on projects providing new insight into
important disease targets and processes
Due Dates: |
October 02 (OSR) Ι October 05 (Sponsor) |
Amount & Project Period: |
Budget not limited - 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-14-284 |
|
NEW
|
October 05 |
All Ranks |
Federal |
Genomics |
Ethical, Legal, and Social Implications (ELSI) of Genomic
Research Regular Research Program
Should propose well-integrated studies using either single or mixed
methods Proposed methods may include data-generating
qualitative or quantitative approaches, legal, economic or
normative analyses, or other analytical or conceptual research
methodologies.
Due Dates: |
October 01 (OSR) Ι October 5 (Sponsor) |
Amount & Project Period: |
Budget not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-14-276 |
|
|
October 05 |
All Ranks |
Federal |
Genomics |
Discovery of in vivo Chemical Probes
NCI is particularly interested in validated hits for targets that address
unmet needs in the prevention, treatment, or diagnosis of
cancer. Strategies that include testing of in vivo chemical
probe activity in primary human tumor cells are encouraged.
Due Dates: |
October 01 (OSR) October 5 (Sponsor) |
Amount & Project Period: |
Budget not limited - 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda Nolan (x6071) |
FOA Link: |
PAR-14-279 |
|
|
October 15 |
All Ranks |
Non-federal |
LGBT Health |
Lesbian Health Fund (LHF) of GLMA:
Health Professionals Advancing LGBT Equality
2014 - 2015 Research Grants
Especially important areas:
1. Understanding social, family, and interpersonal influences as sources of stress or support;
2. Eliminating inequalities in health care;
3. Development and testing of interventions addressing mental and
physical health needs of lesbians and other SMW, including:
eating disorders, obesity, cancer risks, and sexually
transmitted infections;
4. Sexual and reproductive health, including family and parenting issues.
|
|
October 15 |
PIs w/eligible grants |
Federal |
Dietary Supplements |
Research on Dietary Supplements
To support research where supplemental funding would investigate the role of dietary
supplements and/or their ingredients in health maintenance and disease
prevention. Parent awards need not be focused on dietary supplements
Due Dates: |
October 13 (OSR) Ι October 15 (Sponsor)
|
Amount & Project Period: |
$100,000 (Total Costs) - Project and budget periods must
be w/in currently approved project period for existing parent award
|
Eligibility: |
All PIs w/eligible awards (see FOA) - For parent awards that include
multiple PDs/PIs, supplement may be requested by any or all of the PDs/PIs (in accordance w/existing leadership plan)
|
Contact: |
Linda Nolan (X6071)
|
FOA Link: |
PAR-14-201
|
|
NEW |
Standard Dates |
All Ranks |
Federal |
Genomics |
Ethical, Legal, and Social Implications (ELSI) of Genomic
Research Exploratory/Developmental Research Program
Should propose well-integrated studies using either single or
mixed methods Proposed methods may include data-generating
qualitative or quantitative approaches, legal, economic or
normative analyses, or other analytical or conceptual research
methodologies.
Due Date |
October 14 (OSR) Ι October 16 (Sponsor) |
Amount & Project Period: |
R21: $275,000 (Direct Costs) - 2 years
R03: $100,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Links: |
PA-14-278 (R21) Ι
PA-13-277 (R03) |
|
NEW |
Standard Dates |
All Ranks |
Federal |
Chemical Probes |
High Throughput Screening (HTS) to Discover Chemical Probes
To stimulate research in 1) discovery and development of novel, small
molecules for their potential use in studying disease treatments
relevant to the missions of the participating NIH Institutes,
and 2) discovery and/or validation of novel, biological targets
that will inform studies of disease mechanisms. Emphasis on
projects providing new insight into important disease targets
and processes
Due Dates: |
October 14 (OSR) Ι October 16 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-14-283 |
|
NEW |
October 29 |
All faculty |
Federal |
Nanotechnology |
Innovative Research in Cancer Nanotechnology (IRCN)
To enable multi-disciplinary research and transformative discoveries in
cancer biology and/or oncology through the use of
nanotechnology Proposals should address major barriers in
cancer biology and/or oncology using nanotechnology and should
emphasize fundamental understanding of nanomaterial interactions
with biological systems and/or mechanisms of their in vivo
delivery.
Due Dates: |
October 27 (OSR) Ι October 29 (Sponsor) |
Amount & Project Period: |
$450,000/year (Direct Costs) - 5 years |
Eligibility: |
All Faculty - Applicants encouraged to take
advantage of multiple PD/PI option w/one PD/PI representing biology or
oncology fields and another representing the fields of chemistry,
physics, or engineering. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-14-285 |
|
|
November 04 |
All Ranks |
Federal |
GI Microbial Carcinogenesis |
Role of the Microflora in the Etiology of Gastro-Intestinal
Cancer
Hypothesis-driven studies that can define and validate
molecular mechanisms determining microbe-induced carcinogenic
outcomes
Collaborative efforts between scientists currently engaged in GI
cancer research with those in scientific disciplines that may
not otherwise apply their expertise to study cancer etiology and
prevention are encouraged
Due Dates: |
October 31 (OSR) Ι November 04 (Sponsor) |
Amount & Project Period: |
Budgets not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-14-242 |
|
|
November 20 |
All Faculty |
Federal |
Collaboration with NIH |
Pre-application:
Opportunities for Collaborative Research at the NIH Clinical Center
Support for collaborative translational research projects
aligned with NIH efforts to enhance translation of basic
biological discoveries into clinical applications that improve
health.
Due Dates: |
November 18 15 (OSR) Ι November 20 (Sponsor) |
Amount & Project Period: |
This is the pre-application step for the
application process for application to
PAR-13-358 (with a due date in March of 2015). |
Eligibility: |
All Faculty - application must
include at least 1 intramural scientist as a PD/PI or collaborator, and
at least some of the research must be conducted at the NIH Clinical
Center |
Contact: |
Linda Nolan (x6071) |
FOA Link: |
PAR-13-357 |
|